Cash / Money Market reserves may reach 80 billion USD! Novo-Nordisk A/S (NVO.US) and Eli Lilly and Co (LLY.US) are expected to initiate a merger and acquisition frenzy.

Novo-Nordisk A/S and Eli Lilly and Co (LLY.US), two pharmaceutical giants that have achieved great success in the field of weight loss drugs, may trigger a wave of large-scale mergers and acquisitions in 2025.

Zhitong Finance15:45

Express News | Investing 8.5 billion Danish kroner, Novo-Nordisk A/S plans to build a new factory in Denmark.

Breakings16:04

Novo Nordisk's Hiring Binge Leaves Danish Firms Starved of Labor

BNN Bloomberg13:00

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires03:03

Novo-Nordisk A/S (NVO.US) invests 1.2 billion USD to build a factory for rare disease drugs in Denmark.

The Danish pharmaceutical company Novo-Nordisk A/S (NVO.US) announced on Monday that it will invest 8.5 billion kroner (approximately 1.2 billion USD) to build a new factory in Odense, Denmark, for the production of drugs for rare diseases. The company stated that construction work has already begun and is expected to be completed by 2027, at which time the facility is projected to create 400 permanent jobs.

AASTOCKS01:13

Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers

MT Newswires00:38